{
  "id": 18450991,
  "title": "William Blair downgrades CVRx stock rating on reimbursement headwinds",
  "url": "https://urgent.news/2026/11/06/william-blair-downgrades-cvrx-stock-rating-on-reimbursement-headwinds",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-06T05:46:58.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/william-blair-downgrades-cvrx-stock-rating-on-reimbursement-headwinds-93CH-5006531"
  },
  "original_language": "en",
  "account": "William Blair adjusted its rating for CVRx Inc (NASDAQ:CVRX) stock to Market Perform from Outperform on Friday. The downgrade was attributed to reimbursement headwinds facing the company. CVRx reported a 6% year-over-year decline in third-quarter 2026 revenue, amounting to $13.8 million, which fell within its guidance range. The company subsequently revised its full-year 2026 revenue forecast to $56 million to $57 million, down from the previous $58 million to $60 million estimate. The stock has witnessed a 85% decline over the past year, trading at $1.47, but InvestingPro analysis suggests the company remains undervalued at current levels. However, several challenges are impacting CVRx, including reduced prior authorization approval rates from its largest Medicare Advantage payer and turnover among physician champions. The company also faces hurdles in less-experienced sales regions to boost productivity. CVRx is actively working on a second Medicare Advantage coverage policy with Humana, which covers 21% of Medicare Advantage lives, and has reported over 20% procedure growth in its five most seasoned regions. Additionally, the company is progressing with FDA discussions on expanding a real-world evidence label. Despite these efforts, William Blair anticipates that these headwinds will continue into 2027 and is awaiting further clarity on reimbursement and commercial execution. An InvestingPro tip highlights that CVRx is rapidly depleting its cash reserves, with a negative free cash flow of $41 million over the past year.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Economic Times - Top News",
        "title": "Stock Market Holiday 2026: When will BSE & NSE be closed for Diwali? Muhurat trading timings, other key things to know",
        "url": "https://urgent.news/2026/11/06/stock-market-holiday-2026-when-will-bse-nse-be-closed-for-diwali",
        "published": "2026-11-06T05:24:38.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}